Autophagy and reactive oxygen species modulate cytotoxicity induced by suppression of ATM kinase activity in head and neck cancer cells

Oral Oncology

Volumn 48, Issue 11, 2012, Pages 1152-1158

  Lin, Chang Shen ^a   Wang, Yu Chu ^a   Huang, Jau Ling ^b   Hung, Chi Chun ^a,c   Chen, Jeff Yi Fu ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ATM; Autophagy; Head and neck cancer; KU55933; Reactive oxygen species

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ATM PROTEIN; CHLOROQUINE; CISPLATIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; AUTOPHAGY; CANCER CELL; CANCER CELL CULTURE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MICROSCOPY; PRIORITY JOURNAL; WESTERN BLOTTING;

AUTOPHAGY; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CYTOPLASMIC VESICLES; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; MICROSCOPY; MICROTUBULE-ASSOCIATED PROTEINS; MORPHOLINES; PROTEIN-SERINE-THREONINE KINASES; PYRONES; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEINS;

EID: 84867888123     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.05.020     Document Type: Article

References (30)

1. B. Levine, and G. Kroemer Autophagy in the pathogenesis of disease Cell 132 1 2008 27 42
2. K.Y. Chang, S.Y. Tsai, C.M. Wu, C.J. Yen, B.F. Chuang, and J.Y. Chang Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo Clin Cancer Res 17 22 2011 7116 7126
3. A. Ertmer, V. Huber, S. Gilch, T. Yoshimori, V. Erfle, and J. Duyster The anticancer drug imatinib induces cellular autophagy Leukemia 21 5 2007 936 942
4. X. Li, and Z. Fan The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex Cancer Res 70 14 2010 5942 5952
5. Z. Wu, P.C. Chang, J.C. Yang, C.Y. Chu, L.Y. Wang, and N.T. Chen Autophagy blockade sensitizes prostate cancer cells towards src family kinase inhibitors Genes Cancer 1 1 2010 40 49
6. K. Zhu, K. Dunner Jr., and D.J. McConkey Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells Oncogene 29 3 2010 451 462
7. S. Huang, and F.A. Sinicrope Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells Autophagy 6 2 2010 256 269
8. Z.J. Yang, C.E. Chee, S. Huang, and F.A. Sinicrope The role of autophagy in cancer: therapeutic implications Mol Cancer Ther 10 9 2011 1533 1541
9. N. Chen, and V. Karantza Autophagy as a therapeutic target in cancer Cancer Biol Ther 11 2 2011 157 168
10. P.J. McKinnon ATM and ataxia telangiectasia EMBO Rep 5 8 2004 772 776
11. I. Hickson, Y. Zhao, C.J. Richardson, S.J. Green, N.M. Martin, and A.I. Orr Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM Cancer Res 64 24 2004 9152 9159
12. V.N. Ivanov, H. Zhou, M.A. Partridge, and T.K. Hei Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells Cancer Res 69 8 2009 3510 3519
13. Y. Li, and D.Q. Yang The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt Mol Cancer Ther 9 1 2010 113 125
14. S. Fujimaki, Y. Matsuda, T. Wakai, A. Sanpei, M. Kubota, and M. Takamura Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signaling Cancer Lett 319 1 2012 98 108
15. Y.S. Tsai, K.W. Lee, J.L. Huang, Y.S. Liu, S.H. Juo, and W.R. Kuo Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells Toxicology 249 2-3 2008 230 237
16. W.F. Chiang, H.C. Ho, H.Y. Chang, C.C. Chiu, Y.L. Chen, and T.C. Hour Overexpression of Rho GDP-dissociation inhibitor alpha predicts poor survival in oral squamous cell carcinoma Oral Oncol 47 6 2011 452 458
17. T.C. Hour, Y.L. Lai, C.I. Kuan, C.K. Chou, J.M. Wang, and H.Y. Tu Transcriptional up-regulation of SOD1 by CEBPD: a potential target for cisplatin resistant human urothelial carcinoma cells Biochem Pharmacol 80 3 2010 325 334
18. D.J. Klionsky, H. Abeliovich, P. Agostinis, D.K. Agrawal, G. Aliev, and D.S. Askew Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes Autophagy 4 2 2008 151 175
19. S. Ditch, and T.T. Paull The ATM protein kinase and cellular redox signaling: beyond the DNA damage response Trends Biochem Sci 37 1 2012 15 22
20. M. Dewaele, H. Maes, and P. Agostinis ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy Autophagy 6 7 2010 838 854
21. C. Cosentino, D. Grieco, and V. Costanzo ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair Embo J 30 3 2011 546 555
22. A.Y. Patel, T.M. McDonald, L.D. Spears, J.K. Ching, and J.S. Fisher Ataxia telangiectasia mutated influences cytochrome c oxidase activity Biochem Biophys Res Commun 405 4 2011 599 603
23. Z. Guo, S. Kozlov, M.F. Lavin, M.D. Person, and T.T. Paull ATM activation by oxidative stress Science 330 6003 2010 517 521
24. A. Alexander, S.L. Cai, J. Kim, A. Nanez, M. Sahin, and K.H. MacLean ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS Proc Natl Acad Sci USA 107 9 2010 4153 4158
25. J.R. Mercer, K.K. Cheng, N. Figg, I. Gorenne, M. Mahmoudi, and J. Griffin DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome Circ Res 107 8 2010 1021 1031
26. K.W. Lee, Y.S. Tsai, F.Y. Chiang, J.L. Huang, K.Y. Ho, and Y.H. Yang Lower ataxia telangiectasia mutated (ATM) mRNA expression is correlated with poor outcome of laryngeal and pharyngeal cancer patients Ann Oncol 22 5 2011 1088 1093
27. Y. He, Q. Chen, and B. Li ATM in oral carcinogenesis: association with clinicopathological features J Cancer Res Clin Oncol 134 9 2008 1013 1020
28. L. Ai, Q.N. Vo, C. Zuo, L. Li, W. Ling, and J.Y. Suen Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases Cancer Epidemiol Biomarkers Prev 13 1 2004 150 156
29. J. Bolt, Q.N. Vo, W.J. Kim, A.J. McWhorter, J. Thomson, and M.E. Hagensee The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms Oral Oncol 41 10 2005 1013 1020
30. R.A. Parikh, J.S. White, X. Huang, D.W. Schoppy, B.E. Baysal, and R. Baskaran Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma Genes Chromosomes Cancer 46 8 2007 761 775